Ningbo Medvok Medical Co., Ltd. is a high-tech biotechnology company focused on the R&D and production of antigens, antibodies and downstream detection reagents for diagnosis and therapy. The product pipelines cover cardiovascular and cerebrovascular, inflammation, infectious diseases, tumors, hormones and other categories, from raw materials to finished products.
Innovation is in our DNA! Bioantibody keeps developing new technologies. Currently, our products have been delivered to more than 60 countries and cities worldwide. Using the ISO 13485 management system, the product quality is greatly trusted by customers. With the mission "Biotech For A Better Life", we are committed to innovation and providing our best solutions to our customers. We sincerely believe we could make our special contribution to human ecology and health.
The global landscape for hospital testing equipment has shifted from centralized lab testing to a decentralized, integrated model. As a premier China exporter, we understand that hospital diagnostic equipment must bridge the gap between high-throughput laboratory efficiency and bedside rapid response. Our solutions cater to the "Triple-A" requirement of modern healthcare: Accuracy, Accessibility, and Affordability.
In the post-pandemic era, the demand for Molecular Diagnostics (PCR) and Hematology Analyzers has reached unprecedented heights. We provide scalable infrastructures that allow regional hospitals in developing markets to achieve the same diagnostic precision as top-tier metropolitan medical centers.
China's medical equipment manufacturing sector has transitioned from "quantity-driven" to "innovation-led." Companies like Ningbo Medvok leverage sophisticated supply chains and massive R&D investments to produce high-end reagents and instruments. Our industrial footprint ensures that we can maintain supply chain resilience, even during global logistics disruptions, providing a reliable partnership for international distributors and hospital procurement departments.
We are currently integrating AI algorithms into our hematology and biochemistry analyzers. This allows for predictive maintenance of the equipment and automated flagging of abnormal cell morphologies, reducing the burden on laboratory technicians and minimizing human error in critical diagnoses.
Developing high-affinity raw materials is the foundation. We specialize in cardiovascular, inflammatory, and tumor markers to ensure ultra-sensitive detection thresholds.
Transitioning from bulky floor-standing units to portable, handheld devices like our Real-Time PCR systems, enabling diagnostics in remote areas and ambulances.
Our instruments now support Cloud-based data synchronization, allowing doctors to review test results remotely through secure EMR (Electronic Medical Record) integration.
High-throughput automated chemistry and blood analysis for heavy patient loads.
Cost-effective, multi-parameter devices (e.g., 3-part hematology) that optimize space and ROI.
Portable PCR and battery-operated monitors for field hospitals and outreach programs.
As an IVD solutions provider, we have worked and will keep working intensively to support research and foment knowledge and prevention of the diseases. For us, a well-informed society is a healthier society. We care about protecting human health and hope all of society to have access to clean, affordable, and reliable biotechnologies.
Furthermore, our economic development will be compatible with proper conduct in relation to ethics, society, the workplace, the environment and respect for human rights. We think of society as a group of individuals with equal rights and opportunities. In order to materialize this commitment, we have developed the sustainability policy on environmental and social matters.
Medvok Medical
